Stage II Nasopharyngeal Carcinoma AJCC v8
4 clinical trials · Condition
◉ Watch Stage II Nasopharyngeal Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer (NCT06532279) | NRG Oncology | 2025-06-23 |
| A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) (NCT06064097) | National Cancer Institute (NCI) | 2024-06-25 |
| Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer (NCT04870840) | M.D. Anderson Cancer Center | 2020-10-19 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150) | M.D. Anderson Cancer Center | 2016-12-29 |
Track Stage II Nasopharyngeal Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.